Latest profit margin for Eyebright Medical Technology (Beijing) , Ltd.: 13.45% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for 688050.SS is 13.45% as of September 2026. That compares with 24.4% in the prior-year period — down 44.9% year over year. That is above the sector sector average of 13.4%. Investors often review this figure alongside Eyebright Medical Technology (Beijing) , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 688050.SS's profit margin moved from 24.4% to 13.45% — a 44.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eyebright Medical Technology (Beijing) , Ltd.'s valuation or profitability profile.
Against its sector companies, 688050.SS currently prints 13.45% for profit margin, while the sector average sits near 13.4%. That is roughly 0.4% above the sector mean. Large gaps often invite a closer look at Eyebright Medical Technology (Beijing) , Ltd.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Eyebright Medical Technology (Beijing) , Ltd. converts resources into returns. At 13.45%, 688050.SS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 24.4% in the prior-year period — down 44.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 688050.SS's profit margin (13.45%), review year-over-year change from 24.4%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.